Dying on the Waitlist propublica.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from propublica.org Daily Mail and Mail on Sunday newspapers.
With Vermont set to start interscholastic games Friday, claims of no intrasquad COVID-19 transmission ring false
Mid-Vermont Christian School girls basketball Coach Chris Goodwin prepares his team for a defensive conditioning drill during their practice in Quechee, Vt., Friday, Feb. 5, 2021, following Governor Phil Scott s approval to start the winter sports season. (Valley News - James M. Patterson) Copyright Valley News. May not be reprinted or used online without permission. Send requests to permission@vnews.com.
Modified: 2/11/2021 10:15:45 PM
Vermont has for weeks been inching toward a restart of youth winter sports. Last Friday, Gov. Phil Scott finally pulled the trigger, announcing that interscholastic competitions could resume on Friday.
(Photo provided) Parents have been all choked up, especially during this pandemic, asking me whether their baby or toddler might have a breathing problem called bronchiolitis. Well let me put everyone in the nose, or in the know, when it comes to learning about this illness.
–
– Bronchiolitis is a contagious inflammatory disease of the tiny airways that lead into the lungs. It can last one to two weeks, usually occurs in winter and early spring, and usually results in not just inflammation but mucus build-up in those airways, making it hard to breathe especially for those with the tiniest of air passages, meaning babies and, even more, infants born premature or those with a chronic heart or lung disease.
Related Company:
Vermont Business Magazine In large clinical trial conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support such as the need for ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With large numbers of COVID-19 patients requiring hospitalization, these outcomes could also help reduce the overload on intensive care units around the world. Dr Mary Cushman, at the University of Vermont s Larner College of Medicine, is a lead investigator on one aspect of the trial. The trial does not include any Vermont patients.